Stock listing

Hanover:0P8 Penumbra, Inc. Aktie

German listing (Hanover) of Penumbra, Inc. · home listing NYSE:PEN

Follow Penumbra, Inc. into a list and get an email when it puts out news.

Home listing price · NYSE:PEN

$319.12 USD -1.48 (-0.5%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:PEN

Past year +14.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$319.02 – $320.32 USDNov 20, 2026
Volume
205,390 sharesNov 20, 2026
Market cap
$12.58B USDAt the close on Nov 20, 2026 · price × 39.41M shares outstanding
52-week range
$279.69 – $362.41 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$113.9M USDMedian day 320,174 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Penumbra, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:PEN · Home$319.12 USD-1.48 (-0.5%)205,390$319.91$320.32$319.02$320.60Close on Nov 20, 2026
Frankfurt:0P8€291.20 EUR-0.40 (-0.1%)—€292.00€292.00€291.00€291.60Close on Nov 19, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:PEN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$319.12-1.48-0.5%$319.91$320.32$319.02205,390
$320.60+1.49+0.5%$318.58$321.19$318.58214,376
$319.11-1.51-0.5%$319.47$320.60$319.05365,962
$320.62-0.29-0.1%$322.00$322.00$320.06250,366
$320.91+0.140.0%$322.00$322.00$320.63237,582
$320.77-0.95-0.3%$322.78$322.78$320.25214,257
$321.72+0.26+0.1%$321.00$322.24$320.28320,174
$321.46-0.39-0.1%$321.37$321.60$320.21242,364
$321.85+2.64+0.8%$319.00$322.90$319.00251,267
$319.21-1.90-0.6%$319.03$320.72$319.03336,706
$321.11-1.34-0.4%$323.80$324.76$320.28310,516
$322.45+2.43+0.8%$324.30$324.38$322.20374,284
$320.02-1.32-0.4%$320.40$322.11$319.92425,772
$321.34+2.39+0.7%$320.00$321.58$318.55463,515
$318.95-3.02-0.9%$320.56$321.83$318.32497,721
$321.97+3.66+1.1%$318.86$321.97$318.86672,756
$318.31-5.73-1.8%$321.04$321.16$316.35851,272
$324.04-1.18-0.4%$324.70$324.91$323.89407,831
$325.22+0.83+0.3%$323.88$325.58$323.88434,141
$324.39-0.57-0.2%$324.96$325.33$323.88360,025
$324.96+1.40+0.4%$323.50$325.50$323.50472,551
$323.56-0.78-0.2%$324.46$324.46$321.97377,749
$324.34+1.93+0.6%$322.99$324.64$322.43368,832
$322.41+1.55+0.5%$320.30$322.87$320.30272,635
$320.86-0.34-0.1%$322.80$322.80$320.15278,699
$321.20+1.08+0.3%$322.13$322.17$320.09345,435
$320.12+0.110.0%$320.41$320.42$319.25272,341
$320.01-0.95-0.3%$320.93$320.99$318.26216,894
$320.96+1.56+0.5%$319.91$320.97$318.97277,220
$319.40+1.88+0.6%$317.06$319.53$317.06555,297
$317.52+1.17+0.4%$316.61$317.52$316.53379,359
$316.35-0.70-0.2%$316.62$317.74$316.32366,187
$317.05-0.060.0%$317.10$318.01$316.87308,413
$317.11-0.44-0.1%$318.23$318.47$317.10368,274
$317.55-0.45-0.1%$318.37$318.37$316.78239,680
$318.00-0.34-0.1%$318.38$318.93$317.92350,523
$318.34-0.52-0.2%$318.51$319.19$318.24378,219
$318.86-0.32-0.1%$318.73$318.98$318.14189,852
$319.18+0.29+0.1%$318.91$319.33$318.11189,478
$318.89-0.83-0.3%$319.28$319.61$318.17228,148
$319.72+0.28+0.1%$318.98$320.27$318.33482,954
$319.44+0.050.0%$319.46$320.26$318.40410,633
$319.39+0.61+0.2%$319.80$319.80$318.49797,922
$318.78+1.18+0.4%$317.38$318.78$316.77293,927
$317.60-1.27-0.4%$319.19$319.19$317.50994,495
$318.87+0.47+0.1%$319.20$319.20$317.95416,077
$318.40-0.030.0%$317.30$319.33$317.30816,975
$318.43-1.43-0.4%$319.97$319.97$318.18500,842
$319.86+2.13+0.7%$319.30$320.31$318.65269,558
$317.73-0.050.0%$318.54$318.54$317.59152,618
$317.78-1.79-0.6%$319.38$319.38$317.62141,326
$319.57+0.31+0.1%$319.35$320.90$319.21212,689
$319.26-2.91-0.9%$322.61$322.61$319.18380,769
$322.17+1.03+0.3%$321.00$322.72$321.00174,065
$321.14-1.66-0.5%$322.89$323.70$321.14313,873
$322.80+0.22+0.1%$322.48$324.55$322.48220,280
$322.58-0.52-0.2%$325.00$325.00$322.19150,763
$323.10+1.42+0.4%$320.99$323.84$320.97477,149
$321.68+0.68+0.2%$320.83$322.25$320.83234,126
$321.00-2.05-0.6%$323.00$323.13$321.00476,704
$323.05-1.32-0.4%$322.00$323.59$321.89513,090
$324.37+0.62+0.2%$323.70$324.86$323.32271,581
$323.75-1.43-0.4%$324.91$324.91$323.42144,267
$325.18+1.42+0.4%$323.87$325.66$323.87167,123
$323.76-3.08-0.9%$327.12$327.12$323.76210,043

Splits

1 split · NYSE:PEN · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
Ticker
Hanover:0P8
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
Hanover
Currency
EUR

What changed lately

Latest news

All Penumbra, Inc. news

Penumbra, Inc. on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
12 in the last 12 months · 30 in all · newest Oct 29, 2026 · oldest 2025
Calls
23 calls with a replay · 23 with a transcript · latest Nov 5, 2025
Decks
4 decks · latest Jan 15, 2026

Where Penumbra, Inc. is listed

ListingExchangeCountryCurrency
NYSE:PEN · Home listingNYSEUnited StatesUSD
Tradegate:0P8TradegateGermanyEUR
gettex:0P8gettexGermanyEUR
LS Exchange:A14Y65LS ExchangeGermanyEUR
Lang & Schwarz:A14Y65Lang & SchwarzGermanyEUR
BMV:PENBMVMexicoMXN
Stuttgart:0P8StuttgartGermanyEUR
BIVA:PENBIVAMexicoMXN
B3:P2NB34B3BrazilBRL
BOATS:PENBOATSUnited StatesUSD
Dusseldorf:0P8DusseldorfGermanyEUR
Frankfurt:0P8FrankfurtGermanyEUR
Hamburg:0P8HamburgGermanyEUR
Munich:0P8MunichGermanyEUR
Hanover:0P8 · This pageHanoverGermanyEUR
Xetra:0P8XetraGermanyEUR

Valuation

P/E 80.1× against a median of 24.9×: 9th lowest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$11.90B USD
P/E
80.1×
EV/sales
7.6×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
7.9×
Gross margin
68.0%
Operating margin
12.1%
Net margin
10.1%
Debt to equity
0.0×
Beta vs S&P 500
0.18

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Penumbra, Inc. · NYSE:PENUS$12.58BUS$11.90B80.1×7.6×n/a7.9×10.1%0.0×0.18
Zimmer Biomet Holdings, Inc. · NYSE:ZBHUS$19.13BUS$26.24B24.9×3.1×11.6×1.5×8.9%0.6×0.40
Coloplast A/S Class B · OMXCOP:COLO_BUS$15.08BUS$18.16B33.4×4.3×10.5×7.2×10.6%1.5×n/a
Shanghai United Imaging Healthcare Co., Ltd. Class A · SSE:688271US$14.48BUS$13.77B54.1×5.9×n/a4.4×11.5%0.1×n/a
Solventum Corporation · NYSE:SOLVUS$14.36BUS$18.98B92.1×2.3×20.0×3.0×1.9%1.1×0.56
Baxter International Inc. · NYSE:BAXUS$13.14BUS$12.00Bn/a1.0×16.2×2.0×−6.2%0.1×0.97
Smith & Nephew plc · LSE:SN.US$12.54BUS$15.58B20.1×2.5×11.4×2.4×10.1%0.7×n/a
The Cooper Companies, Inc. · NASDAQ:COOUS$11.20BUS$13.59B19.6×3.2×14.6×1.3×13.5%0.3×0.50
Align Technology, Inc. · NASDAQ:ALGNUS$11.02BUS$9.88B22.4×2.4×11.5×2.6×11.8%0.0×1.26
Demant A/S · OMXCOP:DEMANTUS$10.68BUS$13.44B47.1×4.0×17.1×6.5×6.7%1.8×n/a
Insulet Corporation · NASDAQ:PODDUS$9.24BUS$9.62B21.5×3.0×13.9×5.8×13.5%0.6×0.53
Median of the othersUS$12.84BUS$13.68B24.9×3.0×13.9×2.8×10.4%0.6×0.55

Forecasts

2 strong buy · 1 buy · 14 hold · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
362.54 USD · Analysts' mean
EPS, year to Dec 2026
4.90 · 11 analysts
Revenue, year to Dec 2026
1.61B · 7 analysts

Team and board

Officers

OfficerRole
Adam ElsesserChairman and Chief Executive Officer
Maggie YuenChief Financial Officer
Shruthi NarayanPresident
Johanna RobertsExecutive Vice President, General Counsel and Secretary
Ben SorciExecutive Vice President, Operations
Ben TompkinsExecutive Vice President, Development and Compliance
Jason MillsExecutive Vice President, Strategy
James F. BenenatiChief Medical Officer
Lambert ShiuChief Accounting Officer

Board

DirectorRole
Adam ElsesserChairman and Chief Executive Officer
Arani BoseDirector
Bridget O'RourkeDirector
Harpreet GrewalDirector
Janet LeedsDirector
Surbhi SarnaDirector
Thomas C. WilderDirector

Events

Calls

CallWhenStatus
Penumbra (NYSE:PEN) Q3 2025 Earnings CallWed, Nov 05, 2025 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q2 2025 Earnings CallTue, Jul 29, 2025 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q1 2025 Earnings CallWed, Apr 23, 2025 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q4 2024 Earnings CallTue, Feb 18, 2025 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q3 2024 Earnings CallWed, Oct 30, 2024 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q2 2024 Earnings CallTue, Jul 30, 2024 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q1 2024 Earnings CallTue, May 07, 2024 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q4 2023 Earnings CallThu, Feb 22, 2024 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q3 2023 Earnings CallThu, Nov 02, 2023 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q2 2023 Earnings CallTue, Aug 01, 2023 · 4:30 PM ETReplay
All 23 calls
CallWhenStatus
Penumbra (NYSE:PEN) Q1 2023 Earnings CallTue, May 02, 2023 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q4 2022 Earnings CallThu, Feb 23, 2023 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q3 2022 Earnings CallThu, Nov 03, 2022 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q2 2022 Earnings CallThu, Aug 04, 2022 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q1 2022 Earnings CallTue, May 03, 2022 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q4 2021 Earnings CallTue, Feb 22, 2022 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q3 2021 Earnings CallWed, Nov 03, 2021 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q2 2021 Earnings CallMon, Aug 09, 2021 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q1 2021 Earnings CallTue, May 04, 2021 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q4 2020 Earnings CallTue, Feb 23, 2021 · 8:00 AM ETReplay
Penumbra (NYSE:PEN) Q3 2020 Earnings CallWed, Oct 28, 2020 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q2 2020 Earnings CallMon, Aug 03, 2020 · 4:30 PM ETReplay
Penumbra (NYSE:PEN) Q1 2020 Earnings CallThu, May 07, 2020 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Oct 29, 2026 · After close−0.9%
Q2 2026Jul 30, 2026 · After close+0.4%
Q1 2026May 6, 2026 · After close+0.1%
Q4 2025Feb 25, 2026+0.7%
Q3 2025Nov 5, 2025 · After close+17.3%
Q2 2025Jul 29, 2025 · After close+11.9%
Q1 2025Apr 23, 2025 · After close+7.0%
Q4 2024Feb 20, 2025 · Before open−0.2%
Q3 2024Oct 30, 2024 · After close+8.3%
Q2 2024Jul 30, 2024 · After close−3.5%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · After close−3.3%
Q4 2023Feb 22, 2024 · After close−9.3%
Q3 2023Nov 2, 2023 · After close−0.2%
Q2 2023Aug 1, 2023 · After close−9.7%
Q1 2023May 2, 2023 · After close+7.0%
Q4 2022Feb 23, 2023 · After close+2.2%
Q3 2022Nov 3, 2022 · After close+6.7%
Q2 2022Aug 4, 2022 · After close+16.6%
Q1 2022May 3, 2022 · After close−1.9%
Q4 2021Feb 22, 2022 · After close−5.8%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (January 2026)Merger or acquisition11 slidesJan 15, 2026
VIVA 2025Conference21 slidesNovember 2025
Technical Presentation (October 2025)Technical21 slidesOctober 2025
42nd Annual J.P. Morgan Healthcare Conference (January 2024)Conference19 slidesJanuary 2024

Open Decks

IPO

Priced at US$30.00 a share on Sep 17, 2015.

Price
US$30.00 a share
Shares offered
4,000,000 shares of common stock
Offering size
US$120 million
Underwriters' option
Up to 600,000 more shares
Underwriters
J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities, Canaccord Genuity · In the order on the cover
Shares delivered
On or about Sep 23, 2015

Steps

StepWhen
Draft sent to the SEC in confidenceJun 9, 2015
Filed publiclyAug 14, 2015
Amended 3 timesNewest Sep 15, 2015
Shares registered with an exchangeSep 15, 2015
Declared effective by the SECSep 17, 2015
Final prospectus, with the priceSep 18, 2015

Open IPO · From the cover of the final prospectus (424B4) filed Sep 18, 2015

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue1.40B1.19B1.06B847.1M747.6M560.4M547.4M444.9M333.8M263.3M
Cost of revenue461.2M439.6M375.9M311.9M272.2M222.2M175.4M152.4M116.6M92.5M
Gross profit942.4M755.0M682.6M535.2M475.4M338.2M372.0M292.5M217.1M170.8M
Research and development89.8M94.8M84.4M79.4M104.6M90.0M51.7M36.2M31.7M23.9M
Selling, general and administrative663.4M574.0M506.5M449.7M378.3M287.1M272.7M226.4M184.3M148.3M
Operating income189.2M9.28M73.6M6.08M-7.50M-38.9M47.5M-852.0K1.17M-1.35M
Depreciation and amortization17.5M23.7M27.3M24.3M16.4M12.9M8.10M6.17M3.78M2.30M
EBITDA206.7M33.0M100.8M30.4M8.91M-26.1M55.6M5.32M4.95M947.0K
Interest expense1.31M1.42M1.74M1.75M1.93M
Income before tax205.1M20.9M79.7M3.89M-10.5M-38.0M50.1M1.61M2.48M-869.0K
Income tax27.4M6.86M-11.3M5.89M-13.1M-18.8M3.13M-4.40M-3.61M-15.7M
Net income177.7M14.0M91.0M-2.00M5.28M-15.7M48.5M6.60M4.66M14.8M
Earnings per share, basic4.570.362.37-0.050.14-0.441.390.190.140.49
Earnings per share, diluted4.520.362.32-0.050.14-0.441.340.180.130.44

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents186.9M324.4M167.5M69.9M59.4M69.7M72.8M67.8M50.6M13.2M
Short-term investments357.9M15.7M121.7M118.2M195.5M195.2M
Receivables190.0M167.7M201.8M203.4M133.9M114.6M105.9M81.9M58.0M43.3M
Inventory431.5M406.7M388.0M334.0M263.5M219.5M153.0M115.7M94.9M73.0M
Current assets1.22B951.1M915.4M755.7M681.5M617.7M463.1M410.7M382.2M263.8M
Property, plant and equipment117.4M62.6M72.7M65.0M58.9M48.2M51.8M35.4M30.9M21.5M
Goodwill166.8M165.8M166.3M166.0M166.4M8.37M7.66M7.81M8.18M0
Total assets1.83B1.53B1.56B1.37B1.24B823.0M665.9M515.0M476.7M308.3M
Accounts payable34.7M31.3M27.2M26.7M13.4M14.1M15.1M8.18M6.76M4.11M
Current liabilities183.1M158.3M151.1M144.9M123.2M105.9M91.0M66.1M51.6M35.8M
Total liabilities398.9M382.3M377.4M372.0M290.3M185.2M180.3M92.6M76.3M41.7M
Shareholders' equity1.43B1.15B1.18B998.9M953.9M641.5M485.9M422.2M400.4M266.5M
Shares outstanding39.2M38.5M38.7M38.1M37.6M36.4M35.0M34.4M33.7M31.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations238.7M168.5M97.3M-55.7M9.50M-33.2M26.7M28.8M12.7M-12.8M
Capital spending-63.7M-21.2M-15.2M-19.3M-21.2M-24.8M-22.1M-9.60M-12.5M-13.6M
Free cash flow174.9M147.3M82.1M-75.0M-11.7M-58.0M4.54M19.2M159.0K-26.4M
Cash from investing-404.6M77.6M-16.1M54.8M-21.7M-104.1M-12.7M-385.0K-77.7M687.0K
Cash from financing26.5M-87.0M16.2M11.6M836.0K134.9M-8.96M-9.81M104.4M7.13M
Share buybacks0-100.4M00
Change in cash-137.5M156.9M97.6M10.5M-10.3M-3.11M4.93M17.2M37.4M-6.31M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 17, 2026Insider tradeSEC
4 · Change in ownershipNov 17, 2026Insider tradeSEC
4 · Change in ownershipNov 17, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 6, 2026Big-stake noticeSEC
10-Q · Quarterly reportOct 29, 2026Quarterly reportSEC
8-K · Current reportOct 29, 2026ResultsSEC
4 · Change in ownershipOct 16, 2026Insider tradeSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
4 · Change in ownershipAug 19, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 13, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportJul 30, 2026Quarterly reportSEC
8-K · Current reportJul 30, 2026ResultsSEC
8-K · Current reportJun 22, 2026Meeting outcomeSEC
SD · Specialized disclosureMay 29, 2026ESG reportSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
425May 7, 2026Other filingsSEC
8-K · Current reportMay 7, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeApr 30, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 29, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 29, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 29, 2026Meeting noticeSEC
425Apr 23, 2026Other filingsSEC
425Apr 22, 2026Other filingsSEC
425Apr 17, 2026Other filingsSEC
4 · Change in ownershipApr 6, 2026Insider tradeSEC
144 · Notice of proposed saleApr 2, 2026Other filingsSEC
DEFM14AApr 1, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
425Mar 3, 2026Other filingsSEC
144 · Notice of proposed saleMar 2, 2026Other filingsSEC
10-K · Annual reportFeb 25, 2026Annual reportSEC
8-K · Current reportFeb 25, 2026ResultsSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 6, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2026Big-stake noticeSEC
425Feb 4, 2026Other filingsSEC
425Jan 20, 2026Other filingsSEC
4 · Change in ownershipJan 16, 2026Insider tradeSEC
425Jan 16, 2026Other filingsSEC
425Jan 15, 2026Other filingsSEC
425Jan 15, 2026Other filingsSEC
425Jan 15, 2026Other filingsSEC
425Jan 15, 2026Other filingsSEC
425Jan 15, 2026Other filingsSEC
425Jan 15, 2026Other filingsSEC
8-K · Current reportJan 15, 2026ResultsSEC
4 · Change in ownershipJan 8, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
144 · Notice of proposed saleJan 6, 2026Other filingsSEC
144 · Notice of proposed saleJan 2, 2026Other filingsSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 17, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
4 · Change in ownershipDec 9, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 25, 2025Other filingsSEC
144 · Notice of proposed saleNov 21, 2025Other filingsSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 18, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 6, 2025Insider tradeSEC
10-Q · Quarterly reportNov 5, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
144 · Notice of proposed saleNov 4, 2025Other filingsSEC
4 · Change in ownershipOct 17, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
144 · Notice of proposed saleOct 2, 2025Other filingsSEC
144 · Notice of proposed saleOct 1, 2025Other filingsSEC
144 · Notice of proposed saleOct 1, 2025Other filingsSEC
4 · Change in ownershipSep 16, 2025Insider tradeSEC
3 · Initial statement of ownershipSep 16, 2025Insider tradeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
4 · Change in ownershipSep 4, 2025Insider tradeSEC
144 · Notice of proposed saleSep 3, 2025Other filingsSEC
144 · Notice of proposed saleSep 2, 2025Other filingsSEC
8-K · Current reportAug 27, 2025Management or board changeSEC
4 · Change in ownershipAug 22, 2025Insider tradeSEC
144 · Notice of proposed saleAug 20, 2025Other filingsSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 15, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
4 · Change in ownershipAug 13, 2025Insider tradeSEC
144 · Notice of proposed saleAug 13, 2025Other filingsSEC
144 · Notice of proposed saleAug 13, 2025Other filingsSEC
144 · Notice of proposed saleAug 12, 2025Other filingsSEC
4 · Change in ownershipAug 8, 2025Insider tradeSEC
144 · Notice of proposed saleAug 6, 2025Other filingsSEC
10-Q · Quarterly reportJul 29, 2025Quarterly reportSEC
8-K · Current reportJul 29, 2025ResultsSEC
4 · Change in ownershipJul 25, 2025Insider tradeSEC
144 · Notice of proposed saleJul 23, 2025Other filingsSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
144 · Notice of proposed saleJul 9, 2025Other filingsSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
144 · Notice of proposed saleJul 1, 2025Other filingsSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
144 · Notice of proposed saleJun 25, 2025Other filingsSEC
4 · Change in ownershipJun 18, 2025Insider tradeSEC
144 · Notice of proposed saleJun 16, 2025Other filingsSEC
4 · Change in ownershipJun 13, 2025Insider tradeSEC
144 · Notice of proposed saleJun 11, 2025Other filingsSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipMay 30, 2025Insider tradeSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
8-K · Current reportMay 30, 2025Meeting outcomeSEC
144 · Notice of proposed saleMay 28, 2025Other filingsSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
144 · Notice of proposed saleMay 15, 2025Other filingsSEC
4 · Change in ownershipMay 14, 2025Insider tradeSEC
144 · Notice of proposed saleMay 14, 2025Other filingsSEC
4 · Change in ownershipMay 9, 2025Insider tradeSEC
144 · Notice of proposed saleMay 7, 2025Other filingsSEC
4 · Change in ownershipMay 6, 2025Insider tradeSEC
144 · Notice of proposed saleMay 2, 2025Other filingsSEC
4 · Change in ownershipApr 29, 2025Insider tradeSEC
144 · Notice of proposed saleApr 29, 2025Other filingsSEC
4 · Change in ownershipApr 25, 2025Insider tradeSEC
10-Q · Quarterly reportApr 23, 2025Quarterly reportSEC
8-K · Current reportApr 23, 2025ResultsSEC
4 · Change in ownershipApr 18, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
4 · Change in ownershipApr 17, 2025Insider tradeSEC
144 · Notice of proposed saleApr 16, 2025Other filingsSEC
ARS · Annual report to shareholdersApr 16, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 16, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 16, 2025Meeting noticeSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
4 · Change in ownershipApr 4, 2025Insider tradeSEC
PRE 14A · Preliminary proxy statementApr 4, 2025Meeting noticeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
144 · Notice of proposed saleApr 2, 2025Other filingsSEC
144 · Notice of proposed saleApr 2, 2025Other filingsSEC
144 · Notice of proposed saleApr 1, 2025Other filingsSEC
144 · Notice of proposed saleApr 1, 2025Other filingsSEC
144 · Notice of proposed saleMar 31, 2025Other filingsSEC
4 · Change in ownershipMar 27, 2025Insider tradeSEC
4 · Change in ownershipMar 21, 2025Insider tradeSEC
144 · Notice of proposed saleMar 19, 2025Other filingsSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 7, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
4 · Change in ownershipMar 5, 2025Insider tradeSEC
144 · Notice of proposed saleMar 5, 2025Other filingsSEC
144 · Notice of proposed saleMar 4, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
144 · Notice of proposed saleMar 3, 2025Other filingsSEC
8-K · Current reportFeb 21, 2025Management or board changeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
4 · Change in ownershipFeb 19, 2025Insider tradeSEC
10-K · Annual reportFeb 18, 2025Annual reportSEC
8-K · Current reportFeb 18, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC

This page holds 200 of 959 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Penumbra, Inc.’s releases · as of Oct 14, 2026

Common shares
39,414,385
Fully diluted
39,414,385

Fully diluted

LineSharesAs of
Common shares39,414,385Oct 14, 2026

Share count over time

CountShares
Oct 14, 202639,414,385

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BlackRock4.3M10.9%US$1.37BSep 30, 2026
Vanguard3.66M9.3%US$1.16BSep 30, 2026
Hbk Investments L P1.88M4.8%US$599MSep 30, 2026
UBS1.57M4.0%US$501MSep 30, 2026
JPMorgan1.44M3.6%US$459MSep 30, 2026
ExodusPoint Capital Management, LP1.42M3.6%US$454MSep 30, 2026
Arrowstreet Capital, Limited Partnership1.38M3.5%US$440MSep 30, 2026
State Street1.24M3.1%US$394MSep 30, 2026
Goldman Sachs1.17M3.0%US$372MSep 30, 2026
Millennium1.04M2.6%US$331MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Geode Capital786K2.0%US$250MSep 30, 2026
AQR Arbitrage LLC657K1.7%US$209MSep 30, 2026
Morgan Stanley594K1.5%US$189MSep 30, 2026
Whitebox Advisors LLC535K1.4%US$170MSep 30, 2026
Neuberger Berman Group LLC500K1.3%US$159MSep 30, 2026
Capital Group491K1.2%US$156MSep 30, 2026
Balyasny Asset Management L.P.489K1.2%US$156MSep 30, 2026
Citigroup Inc485K1.2%US$154MSep 30, 2026
Tudor Investment Corp Et Al450K1.1%US$143MSep 30, 2026
LMR Partners LLP376K0.95%US$120MSep 30, 2026
Schwab331K0.84%US$105MSep 30, 2026
Two Sigma329K0.83%US$105MSep 30, 2026
Northern Trust325K0.82%US$103MSep 30, 2026
AllianceBernstein321K0.81%US$102MSep 30, 2026
Dimensional300K0.76%US$95.5MSep 30, 2026
Glazer Capital, LLC300K0.76%US$95.5MSep 30, 2026
TIG Advisors, LLC276K0.70%US$87.8MSep 30, 2026
Alpine Associates Management Inc.262K0.67%US$83.4MSep 30, 2026
Magnetar Financial LLC256K0.65%US$81.4MSep 30, 2026
Citadel253K0.64%US$80.4MSep 30, 2026
BNY229K0.58%US$72.8MSep 30, 2026
Hudson Bay Capital Management LP222K0.56%US$70.8MSep 30, 2026
Water Island Capital LLC210K0.53%US$66.8MSep 30, 2026
Capstone Investment Advisors, LLC201K0.51%US$63.8MSep 30, 2026
Birnam Oak Advisors, LP190K0.48%US$60.6MSep 30, 2026
Bank of America183K0.46%US$58.3MSep 30, 2026
Caxton Associates LLP179K0.46%US$57.1MSep 30, 2026
Adage Capital Partners Gp, L.L.C.167K0.42%US$53.1MSep 30, 2026
Champlain Investment Partners, LLC165K0.42%US$52.4MSep 30, 2026
Westchester Capital Management, LLC164K0.42%US$52.2MSep 30, 2026
D. E. Shaw & Co., Inc.147K0.37%US$46.7MSep 30, 2026
Woodline Partners LP143K0.36%US$45.6MSep 30, 2026
Squarepoint Ops LLC128K0.32%US$40.6MSep 30, 2026
HSBC126K0.32%US$40.1MSep 30, 2026
Quarry LP125K0.32%US$39.9MSep 30, 2026
Capula Management Ltd124K0.31%US$39.3MSep 30, 2026
Nuveen115K0.29%US$36.6MSep 30, 2026
Kryger Capital LLC110K0.28%US$34.9MSep 30, 2026
Twin Securities, Inc.109K0.28%US$34.8MSep 30, 2026
Rhumbline Advisers108K0.27%US$34.4MSep 30, 2026

This page holds 50 of 424 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
iShares Core S&P Mid-Cap ETF1.35M3.4%US$425MJun 30, 2026
Vanguard Total Stock Market Index Fund1.19M3.0%US$375MJun 30, 2026
Vanguard Small-Cap Index Fund857K2.2%US$270MJun 30, 2026
Vanguard Small-Cap Growth Index Fund494K1.3%US$156MJun 30, 2026
Vanguard Extended Market Index Fund451K1.1%US$142MJun 30, 2026
SMALLCAP World Fund Inc413K1.0%US$130MJun 30, 2026
iShares S&P Mid-Cap 400 Growth ETF235K0.60%US$74.3MJun 30, 2026
iShares Russell Mid-Cap Growth ETF224K0.57%US$70.8MJun 30, 2026
Fidelity Extended Market Index Fund202K0.51%US$64.4MMay 31, 2026
State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF199K0.51%US$62.9MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Invesco S&P MidCap Momentum ETF190K0.48%US$61.2MJul 31, 2026
iShares U.S. Medical Devices ETF184K0.47%US$58.2MJun 30, 2026
iShares Russell Mid-Cap ETF156K0.40%US$49.4MJun 30, 2026
iShares Russell 1000 Growth ETF145K0.37%US$45.9MJun 30, 2026
Fidelity Mid Cap Index Fund144K0.37%US$46.3MJul 31, 2026
BlackRock Health Sciences Opportunities Portfolio133K0.34%US$42.4MMay 29, 2026
The Merger Fund132K0.33%US$41.6MJun 30, 2026
VIP Contrafund Portfolio125K0.32%US$39.4MJun 30, 2026
Vanguard Health Care Index Fund112K0.28%US$35.6MMay 31, 2026
Schwab U.S. Mid-Cap ETF106K0.27%US$33.8MMay 31, 2026
The Arbitrage Fund95,1020.24%US$30.3MMay 31, 2026
Calamos Market Neutral Income Fund91,8630.23%US$29.5MJul 31, 2026
Schwab U.S. Large-Cap Growth ETF83,4850.21%US$26.6MMay 31, 2026
Fidelity SAI Merger Arbitrage Fund80,0000.20%US$25.7MJul 31, 2026
Champlain MidCap Fund76,0000.19%US$24MJun 30, 2026
Fidelity Total Market Index Fund74,1260.19%US$23.6MMay 31, 2026
U.S. Small Cap Portfolio64,9490.16%US$20.9MJul 31, 2026
American Century U.S. Quality Growth ETF64,9010.16%US$20.7MMay 31, 2026
Vanguard S&P Mid-Cap 400 Index Fund62,6020.16%US$19.9MMay 31, 2026
Vanguard Russell 1000 Growth Index Fund62,5630.16%US$19.9MMay 31, 2026
State Street(R) SPDR(R) S & P 400(TM) Mid Cap Growth ETF60,8390.15%US$19.2MJun 30, 2026
Fidelity Series Total Market Index Fund59,7600.15%US$19MMay 31, 2026
Dimensional U.S. Small Cap ETF59,1930.15%US$19MJul 31, 2026
iShares Core S&P Total U.S. Stock Market ETF50,5450.13%US$16MJun 30, 2026
JPMorgan U.S. Quality Factor ETF50,4750.13%US$16.2MJul 31, 2026
Fidelity Large Cap Growth Index Fund50,1300.13%US$16.1MJul 31, 2026
Janus Henderson Global Life Sciences Fund47,5350.12%US$15MJun 30, 2026
Champlain Small Company Fund44,0000.11%US$13.9MJun 30, 2026
Capital Group U.S. Small and Mid Cap ETF43,8500.11%US$14MMay 31, 2026
Schwab U.S. Large-Cap ETF41,8070.11%US$13.3MMay 31, 2026
Fidelity Mid Cap Growth Index Fund40,7040.10%US$12.9MJun 30, 2026
JNL Mid Cap Index Fund40,1460.10%US$12.7MJun 30, 2026
Vanguard S&P Mid-Cap 400 Growth Index Fund39,3290.10%US$12.5MMay 31, 2026
Nuveen Equity Index Fund35,1820.09%US$11.3MJul 31, 2026
iShares U.S. Equity Factor Rotation Active ETF34,3820.09%US$11MJul 31, 2026
iShares Core S&P U.S. Growth ETF34,2520.09%US$10.8MJun 30, 2026
EQ/Mid Cap Index Portfolio31,8860.08%US$10.1MJun 30, 2026
Vanguard Total World Stock Index Fund30,6580.08%US$9.85MJul 31, 2026
Fidelity Advisor New Insights Fund29,0410.07%US$9.17MJun 30, 2026
Mid Cap Index Fund28,8970.07%US$9.2MMay 31, 2026

This page holds 50 of 325 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Grewal Harpreet
Director
Sale100USD 328.22US$32,822Apr 2, 2026

Big stakes

StakeStakeSharesDateFiling
Vanguard Capital Management LLC5.07%1.99MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Harpreet Grewal
Other companies: Constant Contact Inc (EVP, Chief Financial Officer · Jul 6, 2010 – Feb 9, 2016 · Past); Cimpress plc (Exec VP and CFO · Oct 2, 2006 – Jul 2, 2008 · Past)
Director · Since at least Sep 17, 2015
Sridhar Kosaraju
Other companies: 10x Genomics, Inc. (Member · Since at least Sep 11, 2019); Nevro Corp (Director · Aug 31, 2021 – Apr 3, 2025 · Past)
President · Sep 17, 2015 – Apr 15, 2020 · Past
Jason Mills
Other companies: NeuroOne Medical Technologies Corporation (Director · Since at least Dec 18, 2025)
Executive Vice President, Strategy · Since at least Nov 5, 2026
Maggie S. Yuen
Other companies: AtriCure, Inc. (Director · Since at least Aug 7, 2026)
Chief Financial Officer · Since at least Nov 4, 2026
Maggie Yuen
Other companies: AtriCure, Inc. (Director · Since at least Jun 15, 2021)
Chief Financial Officer · Since at least Dec 2, 2019
Thomas C. Wilder
Other companies: Endologix Inc (Director · May 20, 2010 – Aug 12, 2020 · Past)
Director · Since at least Jan 13, 2017
Adam ElsesserChairman and Chief Executive Officer · Since at least Sep 17, 2015
Arani BoseDirector · Since at least Sep 17, 2015
Ben SorciExecutive Vice President, Operations · Since at least Nov 4, 2026
Ben TompkinsExecutive Vice President, Development and Compliance · Since at least Nov 4, 2026
All 23 people
PersonSeat
Bridget O'RourkeDirector · Since at least Apr 21, 2017
Don W KassingDirector · Sep 17, 2015 – Feb 14, 2025 · Past
James F. BenenatiChief Medical Officer · Since at least Oct 20, 2026
James Robert PrayPresident, International · Sep 17, 2015 – Oct 1, 2021 · Past
Janet LeedsDirector · Since at least Jan 17, 2019
Johanna RobertsEVP, Gen. Counsel & Secretary · Since at least Apr 15, 2021
Kevin James SullivanDirector · Feb 23, 2016 – Aug 31, 2016 · Past
Lambert ShiuChief Accounting Officer · Since at least Dec 2, 2019
Lynn RothmanEVP and Chief Business Officer · Sep 17, 2015 – Oct 1, 2021 · Past
Robert D EvansEVP, Gen. Counsel & Secretary · Sep 17, 2015 – Aug 29, 2018 · Past
Shruthi NarayanPresident · Since at least Sep 1, 2025
Surbhi SarnaDirector · Since at least Oct 2, 2023
Walter Charles WangDirector · Sep 17, 2015 – Mar 4, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Penumbra, Inc.